Literature DB >> 89921

Inhibition of human neutrophil migration by aggregated gammaglobulin.

A Kemp, P Roberts-Thomson, S Brown.   

Abstract

Heat-aggregated human gammaglobulin has been shown to inhibit the random migration of human neutrophils in serum-containing medium. This inhibition was not due to metabolic exhaustion or deactivation of the cells, since migration in the presence of aggregated gammaglobulin and casein as a chemotactic stimulus was not inhibited. The inhibition of migration was not mediated by a negative chemotactic gradient produced as a result of complement activation, and could be demonstrated in complement-depleted serum. Sera obtained from patients with rheumatoid arthritis with evidence of circulating immune complexes were able to significantly inhibit neutrophil migration, indicating that this phenomenon may be a useful means for the detection of circulating immune complexes. It is suggested that aggregated gammaglobulin or immune complexes can inhibit the chemokinetic effect of serum on neutrophils by a reversible interaction with the neutrophil surface, and that this inhibition could contribute to the accumulation of neutrophils at sites of immune complex deposition in vivo.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89921      PMCID: PMC1537718     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils.

Authors:  D A Lawrence; W O Weigle; H L Spiegelberg
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

2.  Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease.

Authors:  R B Johnston; J E Lehmeyer
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

3.  A proposal for the definition of terms related to locomotion of leucocytes and other cells.

Authors:  H U Keller; P C Wilkinson; M Abercrombie; E L Becker; J G Hirsch; M E Miller; W Scottramsey; S H Zigmond
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

Review 4.  Immunologic tissue injury mediated by neutrophilic leukocytes.

Authors:  C G Cochrane
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

5.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

6.  The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.

Authors:  T Wagner; G Abraham; J Baum
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

7.  Effector activating determinants on IgG. I. The distribution and factors influencing the display of complement, neutrophil and cytotoxic B-cell determinants on human IgG sub-classes.

Authors:  I C MacLennan; A Howard; F M Gotch; P G Quie
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

Review 8.  Membrane receptors on neutrophils.

Authors:  P M Henson
Journal:  Immunol Commun       Date:  1976

9.  The release of granule enzymes from human neutrophils stimulated by aggregated immunoglobulins of different classes and subclasses.

Authors:  P M Henson; H B Johnson; H L Spiegelberg
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

10.  Stimulation of human neutrophils by soluble and insoluble immunoglobulin aggregates. Secretion of granule constituents and increased oxidation of glucose.

Authors:  P M Henson; Z G Oades
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

View more
  10 in total

1.  Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.

Authors:  R H Lawrence; T C Sorrelli
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

2.  Changes in normal polymorphonuclear leucocyte motility after ingestion of IgG aggregates.

Authors:  D H Goddard; A P Kirk; K A Brown; D McCarthy; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

3.  Suppression of leucocyte chemokinesis and chemotaxis by human IgA.

Authors:  A S Kemp; A W Cripps; S Brown
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

4.  Inhibition of neutrophil migration by aggregated immunoglobulin attached to micropore membranes.

Authors:  A S Kemp; S Brown
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

5.  Inhibition of neutrophil migration by sera from patients with rheumatoid arthritis.

Authors:  A S Kemp; P Roberts-Thomson; S H Neoh; S Brown
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

6.  A comparison of leukocyte aggregation, leukocyte migration and skin reactivity to recall antigens in patients with AIDS.

Authors:  B Rouveix; F Groult; J J Pocidalo
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

7.  Evaluation of cellular immune response during chronic schistosomiasis in humans by the leukocyte aggregation test and the leukocyte migration inhibition test.

Authors:  B Rouveix; F Derouin; M Levacher
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

8.  Migration of blood and synovial fluid neutrophils obtained from patients with rheumatoid arthritis.

Authors:  A S Kemp; S Brown; P M Brooks; S H Neoh
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

9.  Inhibition of neutrophil migration by serum IgA from patients with IgA nephropathy.

Authors:  J Egido; J Sancho; F Lorente; G Fontan
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

10.  In vitro monocyte maturation in squamous-cell carcinoma of the lung: influence of humoral factors.

Authors:  R G Dent; P J Cole
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.